<code id='BC4B900C5C'></code><style id='BC4B900C5C'></style>
    • <acronym id='BC4B900C5C'></acronym>
      <center id='BC4B900C5C'><center id='BC4B900C5C'><tfoot id='BC4B900C5C'></tfoot></center><abbr id='BC4B900C5C'><dir id='BC4B900C5C'><tfoot id='BC4B900C5C'></tfoot><noframes id='BC4B900C5C'>

    • <optgroup id='BC4B900C5C'><strike id='BC4B900C5C'><sup id='BC4B900C5C'></sup></strike><code id='BC4B900C5C'></code></optgroup>
        1. <b id='BC4B900C5C'><label id='BC4B900C5C'><select id='BC4B900C5C'><dt id='BC4B900C5C'><span id='BC4B900C5C'></span></dt></select></label></b><u id='BC4B900C5C'></u>
          <i id='BC4B900C5C'><strike id='BC4B900C5C'><tt id='BC4B900C5C'><pre id='BC4B900C5C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:774

          A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

          See below for an archived chat with Helen Branswell about these issues and more. 

          advertisement

          knowledge

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Healthy food access boosts outcomes in two studies
          Healthy food access boosts outcomes in two studies

          HealthyFoodRx'slivestreamofacookingclassduringmealprep.DanSocie/AbbotFundInStockton,California,almos

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Readout Newsletter: Zepbound, Valneva's vaccine, and more

          HarryD.Pratt/CDCWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnew